Gram-negative bacteria.
In our screening program for antitumor compounds,a new antitumor antibiotic FR-900482has been isolated from the fermentation broth of Streptomyces sandaensis No. 6897. The taxonomy of the producing strain and the antitumor activity of FR-900482are reported in separate papers1'50.
The present paper describes the production, isolation, physico-chemical properties and biological activities of FR-900482. Fermentation A loopful of mature slant culture of Streptomyces sandaensis No. 6897 was inoculated into a seed medium (160 ml) containing soluble starch 2%, glucose 0.5 %, cotton seed meal 1 %, dried yeast 1 %, corn steep liquor 0.5 % and CaCO3 0.2% (pH 7.0) in a 500-ml Erlenmeyer flasks and cultured at 30°C for 72 hours on a rotary shaker with 7.62 cm throw at 200 rpm.
Fermentation studies were carried out in tank fermentors. A seed culture was shaken in the above mentioned Erlenmeyer flasks and then transferred at the rate of 0.7% to 20 liters of the same seed medium in a 30-liter jar fermentor, which was cultured at 30°C for 48 hours under aeration of 20 liters/minute and agitation of 200 rpm. Eighteen liters of the seed culture were inoculated into 1,760 liters of production medium containing soluble starch 8 %, dried yeast 1 %, peanut powder 3 % and soybean meal 0.5 % (pH 6.2) in a 2,000-liter stainless steel fermentor which was cultured at 31°C for 96 hours under aeration of 880 liters/minute and agitation of 130 rpm.
Antibiotic levels in the fermentation broth and the extracts of FR-900482 were assayed by paper disc agar diffusion methodusing Bacillus stearothermophilus as a test organism and cytotoxic activity against P388 murine leukemia cells in tissue culture.
A typical time course of the fermentation is presented in Fig. 1 .
Isolation and Purification The cultured broth thus obtained was filtered with an aid of diatomaseous earth (125 kg). The filtrate (1,600 liters) was passed through a column of Diaion HP-20 (400 liters). This column was PMV: Packed mycelium volume. Fig. 2 . UV spectrum of FR-900482 (MeOH).
--MeOH, MeOH-HCl, --MeOHNaOH.
washed with water (400 liters) and eluted with 50% aqueous methanol (1,200 liters). The active eluate was concentrated in vacuo to a volumeof 300 liters. Theactive fraction wascharged with a column of Amberlite IRC-50 (H+ form) (300 liters). The column was washed with deionized water (600 liters) and eluted with 0.1 n hydrochloric acid (1,200 liters). The eluate was neutralized with 12 n aqueous sodium hydroxide, and then passed through a column of Diaion HP-20 (200 liters). The Diaion HP-20 column was washed with deionized water (200 liters) and eluted with 50% aqueous methanol (600 liters). The active eluate was concentrated in vacuo to a volume of 10 liters, and thereto was added 15 liters of butanol and then stirred for 10 minutes. This extraction procedure was carried out four times and the obtained extracts were combined (60 liters). Then, to the combined butanol extract was added 240 liters of «-hexane and stirred for 10 minutes. The aqueous layer was separated and to the butanol -w-hexane layer 15 liters of deionized water was added and stirred for 10 minutes. The aqueous layers were combined and concentrated in vacuo to a volumeof 6 liters, and applied to a column of Alumina Oxide AC-1 1 (100 liters). The column was developed with 80 %aqueous isopropyl alcohol and the active eluate was concentrated in vacuo to a volumnof 300 ml. The active fraction was further purified on a column of Toyopearl (HW-40 Fine) (7 liters) using deionized water as an eluent. Fractions containing active material (30 liters) were concentrated in vacuo to 500 ml and then lyophilized to give a crude powder (3 g). The crude powder was dissolved in deionized water so as to make a final concentration of 50 mg/ml and subjected to high performance liquid chromatography (HPLC) purification.
HPLC was carried out on C18 //Bondapack column, 0.79 cm (i.d.) x 30 cm and monitored at 254 nm. Mobil phase was a mixture of methanol and distilled water (1 :9). The active fraction had a retention time of 8 minutes at a flow rate of 6 ml/minute. Oneg of colorless powder of FR-900482 was obtained. The molecular formula of FR-900482 was determined to be C14H15N3O6by the elemental X-ray analysis of its derivative. As can be seen in TLCbehavior (see Table 1 ), FR-900482 exists as an equilibrium mixture of two isomers (A and B), which was shown to be attributable to tautomerism of the anomeric hydroxyl group.
Biological Activities Antimicrobial Activity
Antimicrobial activity of FR-900482 was determined by a serial broth dilution method in bouillon media for Gram-positive and Gram-negative bacteria and in Sabouraud media for fungi and yeasts. Minimun inhibitory concentration (MIC) is expressed in terms of jug/ml after overnight at 37°C for all the bacteria except for Bacillus stearothermophilus at 55°C and 48-72 hours incubation at 28°C for fungi and yeasts. The antimicrobial spectra of FR-900482 are shown in Table 2 .
From the result the antibiotic FR-900482shows a growth inhibition against B. stearothermophilus var. calidolactis C 953 at an extremely low concentration (0.03 jug/ml). However, FR-900482 has weak antimicrobial activities against other bacteria, fungi and yeast.
Antitumor Activity
Cytotoxic activity of FR-900482 was determined as follows. Concentration of the compound required for 50% inhibition of cell growth (IC50; A«g/ml) was examined by plotting the logarithms of the concentration versus the growth rate (percentage of control) of the treated cells. The result is shown in Table 3 .
FR-900482 is effective against leukemia P388, melanomaB16, lymphomaEL4, mammarycarcinoma FM3A, leukemia L1210 and baby hamster kidney (BHK-21) cells at low concentrations.
Acute Toxicity The acute toxicity of FR-900482 was determined in ddY mice (5 weeks old, female) by a single intraperitoneal or intravenous injection of graded doses of FR-900482 into 5 mice. The LD50was approximately 32 mg/kg.
Discussion
The characteristic feature of FR-900482 is that FR-900482 is colorless and fairly soluble in water, despite other traditional antitumor antibiotics are mostly colored and slightly soluble in water. FR-900482 was found to have unique structure 1, which is in tautomeric equilibrium of A and B. Details on the structure and the tautomerism of 1 will be published elsewhere.
FR-900482 was quite active in murine tumor systems in vitro and in vivo2>zK Further the structural relationship of the antitumor activity to the tautomeric equilibrium of FR-900482 is now progress.
